Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.990
+0.100 (3.46%)
Nov 4, 2024, 4:00 PM EST - Market closed
BDTX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 29.7 | 27.11 | 28.39 | 30.04 | 21.36 | 7.58 | |
Research & Development | 57.54 | 59.35 | 64.44 | 96.83 | 48.21 | 21.75 | |
Operating Expenses | 87.24 | 86.46 | 92.83 | 126.87 | 69.57 | 29.33 | |
Operating Income | -87.24 | -86.46 | -92.83 | -126.87 | -69.57 | -29.33 | |
Interest Expense | - | - | - | - | -0 | - | |
Interest & Investment Income | 1.86 | 1.92 | 2.03 | 3.46 | 4.04 | 0.46 | |
Earnings From Equity Investments | - | - | -2.25 | - | - | - | |
Currency Exchange Gain (Loss) | - | - | - | -0 | 0 | 0.01 | |
Other Non Operating Income (Expenses) | 3.84 | 3.27 | 0.18 | - | - | -6.39 | |
EBT Excluding Unusual Items | -81.54 | -81.27 | -92.87 | -123.41 | -65.53 | -35.26 | |
Gain (Loss) on Sale of Investments | 0.99 | -1.17 | -0.54 | -2.19 | -1.73 | - | |
Gain (Loss) on Sale of Assets | - | - | 2.23 | - | - | - | |
Pretax Income | -80.55 | -82.44 | -91.17 | -125.6 | -67.25 | -35.26 | |
Net Income | -80.55 | -82.44 | -91.17 | -125.6 | -67.25 | -35.26 | |
Net Income to Common | -80.55 | -82.44 | -91.17 | -125.6 | -67.25 | -35.26 | |
Shares Outstanding (Basic) | 52 | 44 | 36 | 36 | 33 | 2 | |
Shares Outstanding (Diluted) | 52 | 44 | 36 | 36 | 33 | 2 | |
Shares Change (YoY) | 43.95% | 21.00% | 0.38% | 9.97% | 1485.31% | 2.83% | |
EPS (Basic) | -1.54 | -1.88 | -2.51 | -3.47 | -2.04 | -16.99 | |
EPS (Diluted) | -1.54 | -1.88 | -2.51 | -3.47 | -2.05 | -16.99 | |
Free Cash Flow | -68.28 | -66.75 | -85.27 | -102.86 | -52.29 | -24.7 | |
Free Cash Flow Per Share | -1.30 | -1.52 | -2.35 | -2.84 | -1.59 | -11.90 | |
EBITDA | -86.87 | -86.02 | -92.32 | -126.67 | -69.52 | -29.29 | |
D&A For EBITDA | 0.37 | 0.44 | 0.51 | 0.21 | 0.05 | 0.05 | |
EBIT | -87.24 | -86.46 | -92.83 | -126.87 | -69.57 | -29.33 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.